Health Care & Life Sciences » Pharmaceuticals | Bukwang Pharmaceutical Co. Ltd.

Bukwang Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
130,795
141,687
142,132
138,618
150,743
194,224
Cost of Goods Sold (COGS) incl. D&A
58,947
58,900
56,536
60,726
68,051
77,356
Gross Income
71,848
82,788
85,596
77,891
82,693
116,867
SG&A Expense
48,855
54,429
62,308
69,352
75,017
81,741
EBIT
22,993
28,358
23,288
8,539
7,676
35,126
Unusual Expense
141
-
-
-
-
3,038
Non Operating Income/Expense
1,584
431
7,283
11,654
6,729
152,540
Interest Expense
293
-
-
-
-
-
Pretax Income
25,980
29,917
31,887
20,947
14,883
191,056
Income Tax
6,051
5,983
6,701
5,224
3,793
45,398
Equity in Affiliates
396
317
47
85
-
-
Consolidated Net Income
19,532
23,616
25,139
15,807
11,091
145,657
Net Income
19,532
23,616
25,139
15,807
11,091
145,670
Net Income After Extraordinaries
19,532
23,616
25,139
15,807
11,091
145,670
Net Income Available to Common
19,532
23,616
25,139
15,807
11,091
145,670
EPS (Basic)
433.88
555.79
584.85
400.91
267.00
2,322.55
Basic Shares Outstanding
45
42
43
39
42
63
EPS (Diluted)
433.73
555.99
584.44
400.68
266.88
2,322.55
Diluted Shares Outstanding
45
42
43
39
42
63
EBITDA
30,625
34,035
28,415
14,237
13,776
42,002
Non-Operating Interest Income
1,836
1,989
1,316
754
425
948
Equity in Affiliates (Pretax)
-
-
-
-
54
598

About Bukwang Pharmaceutical Co.

View Profile
Address
7 Sangdo-ro
Seoul SL 06955
Korea, Republic Of
Employees -
Website http://www.bukwang.co.kr
Updated 07/08/2019
Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include gastrointestinal, central nervous system and metabolic drugs. The company also sells household supplies and gift sets.